This suppression of NF-κB activity directly translates into reduced expression of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β, which are fundamental for tumor progression, angiogenesis, and immunosuppression [108,114]. The gene discussed is NFKB1; the disease is neoplasm.